IES Diagnostics

Redefining disease detection and treatment with earlier, more accurate diagnosis

IES &npsp; Home Technology Overview Meet the Team Investor Information IES in the News Contact Us IES Diagnostics, Inc.. Redefining disease detection and treatment with earlier, more accurate diagnosis Imagine the benefits of detecting breast cancer before a mammogram can show it. Or confirming an infectious viral disease days to weeks before contagion. IES Diagnostics, Inc. has the first and only assay (test) for detecting and quantifying all of the unique interferon signatures for any disease or virus with an interferon reaction. With IES Diagnostics' interferon signature assay, science and medicine have a sensitive, accurate tool to detect and diagnose disease and infection earlier. These signatures also provide disease-specific knowledge that can lead to new therapies. Interferon-based therapies use the body's own immune system to fight disease. The result: targeted, effective treatment options with fewer side effects. Interferon-associated diseases can include: